Abstract
Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.
Keywords: Lung cancer, radiosurgery, non small cell, body radiosurgery, extracranial radiosurgery
Current Cancer Therapy Reviews
Title: Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer
Volume: 5 Issue: 4
Author(s): Joshua D. Lawson, Ajay Sandhu, Steve Jiang and Arno J. Mundt
Affiliation:
Keywords: Lung cancer, radiosurgery, non small cell, body radiosurgery, extracranial radiosurgery
Abstract: Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.
Export Options
About this article
Cite this article as:
Lawson D. Joshua, Sandhu Ajay, Jiang Steve and Mundt J. Arno, Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer, Current Cancer Therapy Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339409789712636
DOI https://dx.doi.org/10.2174/157339409789712636 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coordinated Expression of Pax-5 and FAK1 in Metastasis
Anti-Cancer Agents in Medicinal Chemistry Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry Thymidylate Synthase Gene in Pharmacogenetics
Current Pharmacogenomics Cellular Toxicity and Apoptosis Studies in Osteocarcinoma Cells, a Comparison of 177Lu-EDTMP and Lu-EDTMP
Current Radiopharmaceuticals Designing of Novel Carbonic Anhydrase Inhibitors and Activators
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Lessons Learned from the Irinotecan Metabolic Pathway
Current Medicinal Chemistry Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Multifunctional Materials for Cancer Therapy: From Antitumoral Agents to Innovative Administration
Current Organic Chemistry The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Detection of Squamous Cell Carcinoma Antigen with Micro- and Nanogap Interdigitated Electrodes and Gold Nanoparticles
Micro and Nanosystems Sources of β-Cells for Cell Therapy in Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils
Current Pharmaceutical Design Finding Drug Targets Through Analysis of the Platelet Transcriptome
Current Pharmaceutical Design Synthesis and Antitumor Activity of Novel 4-Chloro-3-Arylmaleimide Derivatives
Letters in Drug Design & Discovery Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy
Current Angiogenesis (Discontinued) Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA The Offer of Chemistry to Targeted Therapy in Cancer
Recent Patents on Biotechnology